Ax­some and Het­ero set­tle patent fight over sleep dis­or­der drug

Het­ero Labs could launch its gener­ic sleep dis­or­der drug as ear­ly as 2040 un­der a set­tle­ment deal with Ax­some Ther­a­peu­tics.

The set­tle­ment, an­nounced Tues­day, re­solves …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER